‘Revamp E-Prescription Rules': Chemist Lobby Asks For Mandatory ‘Dispensed' Stamp To Curb Re-Use
The letter flagged that a patient could use the same prescription as a soft copy or a printout of the soft copy at different pharmacies to repeatedly purchase the same medicines
The Indian Pharmaceutical Association (IPA) has written to the apex drug regulator demanding 'urgent modifications" to the current rules governing e-prescribing and e-prescriptions to 'prevent inconvenience, misuse and contravention of laws".
In a detailed letter, seen by News18, the lobby of pharmacists has pointed out loopholes in the country's telemedicine practice guidelines and the health ministry's e-Sanjeevani guidelines. The letter sent to the Drugs Controller General of India (DCGI) on June 9 highlights concerns regarding the current guidelines, which allow prescriptions to be sent directly to patients following teleconsultations.
'The issue is that the same prescription, as a soft copy or a printout of the soft copy, could be shown or used by the patient at different pharmacies to repeatedly purchase the same medicines listed on it. This can lead to repeat dispensing and misuse and is detrimental to public health," the letter said. It added that current guidelines lack 'any means of checking, confirming, or stopping this".
The IPA has called for the Drugs & Cosmetics Act and Rules to be revised so that 'the pharmacist must put a 'Dispensed' stamp on an original printout of the prescription," and that this provision be expanded to cover e-prescriptions as well.
Adapt the global ecosystem
According to the letter, which is also sent to the Directorate General of Health Services (DGHS) and the Pharmacy Council of India (PCI), e-prescribing systems are globally proven to enhance efficiency and safety, but India must tailor its approach to local conditions.
The letter cites the example of Australia, stating that the country also introduced electronic prescribing in May 2020 after they built a robust system that allows doctors to electronically prescribe medications to patients in the form of an encrypted QR code or text message.
The catch here is that upon visiting the pharmacy of his choice, the patient shows the QR Code or text message, and the pharmacy scans it. Following this, the prescription is generated. 'The safety factor here is that the patient cannot repeatedly use the same prescription," the letter said.
What should India do?
'We request you to please understand the situation: Very often, such e-prescriptions will be from doctors who are not from the patient's city or state. The pharmacist to whom the patient brings the prescription is in a dilemma as to whether the prescription is authentic or not."
To eliminate such ambiguity, the IPA in the letter suggests a systemic overhaul. 'The law must mandate that the doctor either electronically send the prescription directly to the pharmacy or provide it in an encrypted mode to the patient, which only a pharmacy can decode, and not the patient."
Highlighting the role of the Ayushman Bharat Digital Mission (ABDM), one of the flagship schemes of the Modi government, the letter said, 'The ABDM is already in the process of providing unique identities to pharmacies and pharmacists; integrating the receipt and access of e-prescriptions should be a natural extension of this initiative."
Experts hold a different view
While the IPA has called for a system that withholds direct prescription access from consumers, experts News18 spoke to hold a different view.
'The intention of IPA is in the right direction, but it won't be correct to take away the rights of patients. This will shift all power into the hands of pharmacists and pharmacies," said a former official from the National Medical Council (NMC) who was part of the panel framing the telemedicine guidelines.
Echoing a similar observation, another official, an industry veteran running a successful e-pharmacy firm, told News18 that the suggestion 'restricts choice for a consumer and structurally will create a doctor-pharmacy nexus, taking away the freedom of choice from a consumer".
'Also, if the pharmacy to which the prescription goes does not have all the medicines in the prescription, which is very normal – then the consumer has no method of access," he said, adding that the pharmacies have no incentive to provide service and affordability to the patients since the consumer is helpless and dependent on them.
Location :
New Delhi, India, India
First Published:
June 10, 2025, 09:36 IST
News india 'Revamp E-Prescription Rules': Chemist Lobby Asks For Mandatory 'Dispensed' Stamp To Curb Re-Use
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
14 hours ago
- The Hindu
Eluru Collector stresses achievement of agricultural targets by July end
Eluru Collector K. Vetri Selvi directed officials from Agriculture and allied departments to intensify efforts to meet all the set targets by the end of July, to support the economic development of the district and the State. Speaking during a video conference meet with the officials on Monday, she reviewed progress on multiple key initiatives, including oil palm plantation, micro-irrigation, Annadata Sukhibhava, CCR cards, e-Crop registration, fertiliser distribution, mango crop procurement, crop insurance, and farm mechanisation. Ms. Vetri Selvi emphasised the completion of the oil palm plantation across 5,169 hectares identified so far, by the end of July. For the current year, the district has been tasked with bringing 13,000 hectares under oil palm cultivation during both Kharif and Rabi seasons. She instructed officials to implement this plan in a phased manner, and to promote awareness at the grassroots level through Rythu Seva Kendras to encourage new farmers. Special focus must be placed on mandals with lower coverage to meet targets. For areas where plantations are already completed, micro-irrigation systems must be installed promptly, she added. The Collector said that efforts should be taken to achieve this year's target of disbursing ₹375 crore in crop loans to tenant farmers, ensuring that no eligible farmer is left out. She also directed that the establishment of food processing units should be expedited and that e-Crop registration be conducted meticulously, as it plays a crucial role in providing compensation for crop loss. In addition, she called for greater awareness on crop insurance among farmers and ordered timely completion of soil health testing, with health cards to be distributed to farmers by August. District Horticulture Officer S. Rammohan, District Agriculture Officer Habib Basha, and several officials from Agriculture and Horticulture departments across the mandals participated in the meeting.
News18
18 hours ago
- News18
No Link Between Covid Vaccine & Sudden Cardiac Deaths: Karnataka Govt Research Amid Hassan Surge
Dr KS Ravindranath, Director, Sri Jayadeva Institute of Cardiovascular Sciences and Research, said, 'We haven't seen a direct link between vaccine or COVID and heart attacks." Amid the surge in heart attack fatalities in Hassan district, a research commissioned by the Karnataka government prior to the incident has found no causal link between Covid-19 vaccines and sudden cardiac deaths. The report has attributed the rise to an increase in conventional risk factors such as hypertension, obesity, and diabetes. Speaking to CNN-News18, Dr KS Ravindranath, Director of the Sri Jayadeva Institute of Cardiovascular Sciences and Research, said, 'We haven't seen a direct link between vaccine or COVID and heart attacks." 'Risk factors have gone up post Covid' Dr Ravindranath highlighted that their observational pilot study at Jayadeva Hospital, examining over 200 patients under 45 in April and May, did not find an association between premature cardiovascular disease and a prior history of COVID-19 infection or vaccination. But he highlighted that the risk factors had gone up significantly post COVID. 'Post-Covid, we have seen a 6-8% increase in other risk factors such as hypertension, obesity, diabetes, etc.," Dr Ravindranath noted, emphasising the shift in risk profiles. He further clarified that these increases are also observed in younger demographics (20-30 year olds), attributing it to stress, lifestyle changes, and potential hormonal shifts post-Covid, alongside job losses. 'Hassan incident in line with broader trend' Regarding the ongoing probe into deaths in Hassan district, Dr Ravindranath clarified that it's not an isolated epidemic, but rather in line with broader trends. 'What we have seen is that most of the private hospitals there, if you look at most of the people admitted there due to heart attacks, 200 plus," he explained. 'Any heart attack has a 5-6% mortality rate, up to 8% sometimes, in that range, mortality is known. So when the numbers are more, obviously the deaths are severe." He added that India's incidence of heart attacks has generally risen compared to Western countries, occurring about 10 years earlier on average. The report's recommendations include establishing a cardiac surveillance program, a national registry for sudden cardiac deaths among young adults, routine heart screenings at the school level, and public health campaigns promoting healthy lifestyles to address the growing burden of cardiovascular diseases. On Karnataka CM Siddaramaiah speaking on the possible link between the vaccine and heart attack, Dr Ravindranath said that a member of civic society had petitioned the CM. 'There is a belief among people and health professionals that they are linked. So to clear the doubts of the public, he had asked whether the vaccine could cause it. The expert committee did not find a link," he said. 'Need for post-mortem' Dr Ravindranath stressed on the need for post-mortem for cases of heart failures, registry of sudden cardiac deaths of youngsters, health checks of high school children to discern heart-related issues. On the Hassan case, he said, 'We have asked for details and sent a questionnaire to the local health officials to understand what happened there…Compared to Western countries, heart attacks take place in India 10 years younger. We have seen a 15 per cent increase in youngsters coming to Jayadeva to check on their heart function." Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : anti covid vaccine cardiac arrest heart attacks news18 specials Location : Bengaluru, India, India First Published: July 07, 2025, 17:15 IST News india No Link Between Covid Vaccine & Sudden Cardiac Deaths: Karnataka Govt Research Amid Hassan Surge
News18
a day ago
- News18
If Vaccines Hadn't Saved Us From Covid-19, We Wouldn't Be Here To Question Heart Attacks
Last Updated: There is no conclusive proof that Covid vaccines directly caused a spike in heart attacks but we can't ignore that Covid-19 itself has left behind a legacy of cardiovascular damage The rise in heart-related complications and sudden deaths post-Covid-19 has triggered several debates, especially around the role of vaccines. Social media amplifies claims—often anecdotal, rarely scientific—linking Covid-19 vaccines to cardiac issues. But here's a fundamental question: If these vaccines hadn't been developed in record time, would we have even lived long enough to speculate on their side effects? The latest debate was triggered by a post on the social media platform X, where Karnataka's Chief Minister Siddaramaiah wrote on July 1: 'In the past month alone, in just one district of Hassan, more than twenty people have died due to heart attacks. The government is taking this matter very seriously… It cannot be denied that the hasty approval and distribution of the Covid vaccine to the public could also be a reason for these deaths, as several studies worldwide have recently indicated that COVID vaccines could be a cause for the increasing number of heart attacks…" In response, what we saw throughout last week was a coordinated and deliberate effort from the Centre, leading medical institutions, and vaccine manufacturers to rebuild and reinforce public confidence in Covid-19 vaccines. Siddaramaiah's claim was strongly rebutted, not only by government-run institutions but also by top pharmaceutical executives, researchers, and well-known doctors. Sample this: The Indian Pharmaceutical Alliance (IPA)—the lobby of domestic pharmaceutical companies representing Sun Pharma, Glenmark, Lupin, Cipla and many others—issued a strong statement supporting Covid-19 vaccines. Industry leaders like Kiran Mazumdar-Shaw of Biocon and Samir Mehta of Torrent Pharma also publicly backed vaccine safety and dismissed the unfounded claims. Top doctors from AIIMS and scientists at ICMR have taken to public platforms to bust myths and explain the science, stressing that panic must not replace facts. The Serum Institute of India (SII)—manufacturer of India's poster boy vaccine Covishield—also reaffirmed that Covid-19 vaccines are safe, scientifically validated, and critical in saving lives. Given that over 170 crore doses of Covishield have been administered out of the 200+ crore total vaccine doses in India, this clarification is not just welcome but vital. These clarifications were essential in addressing the growing public anxiety around sudden cardiac deaths, particularly among younger people. While these incidents are tragic and deserve a detailed investigation, the Union government has made it unequivocally clear: these deaths should not be automatically linked to Covid-19 vaccination. Let's understand this scientifically. As of today, there is no conclusive evidence that Covid-19 vaccines directly caused a spike in heart attacks or sudden cardiac arrests in India. However, we must not ignore a crucial truth: Covid-19 itself has left behind a legacy of cardiovascular damage. The virus is known to inflame blood vessels and affect heart muscle tissue. A 2022 study in Nature Medicine found a 63 per cent higher risk of heart attack in patients within a year of Covid infection. Multiple global studies, including those published in respected medical journals such as The Lancet and the New England Journal of Medicine, have shown that the risk of myocarditis and other heart complications is higher after a Covid-19 infection than after vaccination. A study conducted by the Indian Journal of Medical Research—a peer-reviewed publication supported by ICMR—concluded that Covid-19 vaccination was not associated with an increased risk of unexplained sudden death among young adults. On the contrary, the study documented that vaccination reduced the risk of unexplained sudden death in this age group. The Indian Council of Medical Research (ICMR) and the National Technical Advisory Group on Immunisation (NTAGI) have reiterated that adverse events following immunisation (AEFIs) remain extremely rare. India's official AEFI data shows less than 0.01 per cent serious reactions among the more than 2.2 billion doses administered. Add to this another critical factor: Indians are more genetically susceptible to heart diseases than Western populations. According to a Lancet Regional Health Southeast Asia study published in February 2023, the cardiovascular burden in India is higher than the global average. The age-standardised death rate globally is 233 deaths per 1,00,000, while for India it is 282 per 1,00,000. Yet, unfounded narratives continue to gain traction—some fuelled by misinformation, others by genuine grief seeking answers in a complex post-pandemic landscape. What the available evidence shows is that vaccines, by reducing the severity and spread of the virus, likely played a role in limiting long-term cardiovascular consequences. They weren't just about immediate survival—they bought us time and prevented the invisible wave of complications that continues to unfold. Even if science someday finds a small causal link between certain vaccines and rare cardiac events, we must remember: public health is about trade-offs. During a pandemic, decisions must be made under pressure, aiming to save as many lives as possible. Vaccines were not perfect and they were never claimed to be. What they were, and remain, is effective and life-saving on a population scale. It's also essential to acknowledge the wider ecosystem of risk: lockdown-induced sedentary lifestyles, elevated stress, mental health challenges, and delayed chronic care. And also, the genetic structure of Indians, which is vulnerable to metabolic resistance, hence, diabetes and cardiovascular diseases develop relatively easily. These all contribute to rising cardiac cases—and must be part of the conversation. Blaming vaccines alone oversimplifies a deeply layered issue. top videos View all In short, this is not a defence of pharmaceutical companies or vaccine makers who profited heavily during the pandemic, nor is it a dismissal of the real grief of those who lost loved ones. This is a call for nuance. We need to look at the full picture, not just one side of the story. Let's continue investigating, let's strengthen pharmacovigilance and monitoring across India. Remember, we are alive to debate the side effects because the vaccines worked. Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : AIIMS COVID-19 vaccine covishield health matters Kiran Mazumdar-Shaw news18 specials Serum Institute of India Siddaramaiah Location : New Delhi, India, India First Published: July 07, 2025, 10:00 IST News india If Vaccines Hadn't Saved Us From Covid-19, We Wouldn't Be Here To Question Heart Attacks
